NCT04602221View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

August 1, 2022

Study Completion Date

August 12, 2022

Conditions
Healthy
Interventions
DRUG

Lamotrigine

Tablet

DRUG

BI 409306

Film-coated tablet

DRUG

Placebo

Tablet, Film-coated tablet

DRUG

BI 425809

Film-coated tablet

Trial Locations (2)

90806

Collaborative Neuroscience Research, LLC, Long Beach

08053

Hassman Research Institute, Marlton

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04602221 - A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine | Biotech Hunter | Biotech Hunter